HDAC3 and ischemic stroke: In the current study, we focused on the role of HDAC3 in microglia-mediated neuroinflammation during ischemic stroke and found that HDAC3 deficiency in microglia ameliorated acute I/R-induced microglial activation and inflammation, indicating that targeting HDAC3 may be a novel strategy for the treatment of ischemic stroke.